Concepedia

Sanchita Mourya

SM

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2018

Affiliations

Brod Group(Current)

Ascendis Pharma (Denmark)

Sanchita Mourya is an author at Brod Group specializing in clinical trials, pharmacotherapy, and medicine.

Top concepts

Publications per year

2018–2021

4

Publications

4

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

Aliya Khan, Lars Rejnmark, Mishaela R. Rubin et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 61 citations · Full text

A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults

David Karpf, Susanne Pihl, Sanchita Mourya et al. · Journal of Bone and Mineral Research · 2020 · 45 citations · Full text

, , +15

Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).

Martin J.S. Dyer, Sven de Vos, Jia Ruan et al. · Journal of Clinical Oncology · 2018 · 17 citations

, , +16

Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES)

Meryl Brod, Lori McLeod, Denka Markova et al. · Journal of Patient-Reported Outcomes · 2021 · 14 citations · Full text

1–4 of 4